Testosterone screening will become mandatory for male service members aged 30 and older under new Pentagon medical guidelines. The policy applies to active-duty and reserve personnel and takes effect immediately. Meanwhile, younger male service members can receive testing when doctors identify possible warning signs. Officials say the program aims to identify hormonal issues that could affect health and military readiness.
Defense Secretary Pete Hegseth announced the screening initiative in July before the Pentagon issued its detailed medical guidance. At the time, Hegseth said the department wanted service members to maintain appropriate testosterone levels for demanding military duties. He also connected the policy with long-term health, physical resilience, and continued readiness after military service. Therefore, the department presents the program as both a health measure and readiness initiative.
Under the new guidelines, male troops aged 30 and above will receive mandatory blood tests. However, younger men will not face routine testing unless circumstances indicate a potential medical concern. Doctors can request testing when symptoms or other clinical information suggest possible hormonal problems. As a result, the policy creates different screening requirements based primarily on age and medical circumstances.
Service members who receive low testosterone results may undergo additional medical evaluation. Furthermore, military healthcare providers can determine whether treatment could benefit an individual based on clinical circumstances. When appropriate, eligible men may receive voluntary hormone replacement therapy through military medical services. However, the guidelines do not make hormone treatment mandatory for personnel with low testosterone levels.
Testosterone plays several important roles in male development and physical health. Levels generally rise during puberty and contribute to muscle development, body hair growth, and reproductive functions. However, testosterone levels can gradually decline as men reach their thirties and later adulthood. Consequently, military officials say identifying significant hormonal deficiencies could help address health concerns among older service members.
The policy also includes guidance involving female service members, although routine testosterone testing will not apply to women. Instead, medical personnel will monitor certain symptoms, including fatigue and menstrual disruptions. Those symptoms can sometimes accompany hormonal or energy-related health conditions. Additionally, the guidelines outline circumstances in which doctors could consider testosterone treatment for certain women.
The Pentagon says the standardized approach should help military healthcare providers identify and manage hormonal concerns more consistently. At the same time, officials say the broader goal involves maintaining a healthy and capable force. The department believes earlier identification of medical issues could support service members throughout their military careers. Therefore, the policy combines preventive healthcare with the department’s broader readiness objectives.
However, some medical experts have questioned whether broad testing will produce meaningful improvements in military readiness. They argue that universal screening could identify people who do not require treatment. In addition, doctors have raised concerns about unnecessary medical interventions following borderline or abnormal test results. These concerns have created debate over whether mandatory testing offers enough benefits to justify its broad application.
Medical researchers and specialists also point to the limited evidence surrounding universal testosterone screening among military personnel. In particular, they question whether identifying low testosterone automatically translates into improved performance or operational readiness. Consequently, further medical evaluation may play an important role in determining how the policy affects service members.
The military continues to prohibit testosterone use for performance enhancement without medical authorization. Service members cannot use testosterone simply to improve physical performance outside approved medical treatment. Meanwhile, the new guidelines focus on identifying genuine health concerns rather than encouraging performance-enhancing hormone use.
The Food and Drug Administration also plans to convene experts to discuss testosterone’s medical use later this month. That meeting could provide additional discussion about appropriate testing, treatment, and potential risks. Meanwhile, the Pentagon will begin implementing the new screening requirements across eligible service members.
Testosterone screening represents a significant change in how the military approaches hormonal health among older male personnel. The policy combines mandatory testing with voluntary treatment and additional medical evaluation. Although Pentagon officials emphasize health and readiness benefits, medical experts continue debating the approach. Ultimately, the program’s impact will depend on how consistently doctors apply the guidelines and assess individual patients.
Testosterone screening could therefore become an important part of the military’s broader approach to preventive healthcare. However, officials and medical professionals will likely continue evaluating its effectiveness as implementation expands. For now, the Pentagon has established age-based testing requirements while maintaining clinical judgment for treatment decisions.
